These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33111645)

  • 1. PDE-5i Management of Erectile Dysfunction After Rectal Surgery: A Systematic Review Focusing on Treatment Efficacy.
    Notarnicola M; Celentano V; Gavriilidis P; Abdi B; Beghdadi N; Sommacale D; Brunetti F; Coccolini F; de'Angelis N
    Am J Mens Health; 2020; 14(5):1557988320969061. PubMed ID: 33111645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: a randomized, double-blind, placebo-controlled trial.
    Park SY; Choi GS; Park JS; Kim HJ; Park JA; Choi JI
    Surgery; 2015 Jan; 157(1):64-71. PubMed ID: 25482466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-5 Inhibitors and Vacuum Erection Device for Penile Rehabilitation After Laparoscopic Nerve-Preserving Radical Proctectomy for Rectal Cancer: A Prospective Controlled Trial.
    Deng H; Liu D; Mao X; Lan X; Liu H; Li G
    Am J Mens Health; 2017 May; 11(3):641-646. PubMed ID: 27561925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of psychological interventions alone, or in combination with phosphodiesterase-5 inhibitors, for the treatment of erectile dysfunction:A systematic review.
    Atallah S; Haydar A; Jabbour T; Kfoury P; Sader G
    Arab J Urol; 2021; 19(3):310-322. PubMed ID: 34552782
    [No Abstract]   [Full Text] [Related]  

  • 5. The Phosphodiasterase 5-Inhibitors (PDE-5i) for Erectile Dysfunction (ED): A Therapeutic Challenge For Psychiatrists.
    Koon CS; Sidi H; Kumar J; Xi OW; Das S; Hatta MH; Alfonso C
    Curr Drug Targets; 2018; 19(12):1366-1377. PubMed ID: 28215172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: A retrospective, observational study based on healthcare claims and national death index data.
    Kloner RA; Stanek E; Crowe CL; Singhal M; Pepe RS; Bradsher J; Rosen RC
    J Sex Med; 2023 Jan; 20(1):38-48. PubMed ID: 36897243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vacuum therapy for erectile dysfunction that fails to respond to PDE-5i: report of 70 cases].
    Li P; Shen YJ; Liu TQ; Ma M; Zhang SJ; Wang YX; Tian RH; Chen HX; Ping P; Chen XF; Li Z; Li Z
    Zhonghua Nan Ke Xue; 2013 Mar; 19(3):236-40. PubMed ID: 23700730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis.
    Tsertsvadze A; Fink HA; Yazdi F; MacDonald R; Bella AJ; Ansari MT; Garritty C; Soares-Weiser K; Daniel R; Sampson M; Fox S; Moher D; Wilt TJ
    Ann Intern Med; 2009 Nov; 151(9):650-61. PubMed ID: 19884626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence rate of prostate cancer in men treated for erectile dysfunction with phosphodiesterase type 5 inhibitors: retrospective analysis.
    Chavez AH; Scott Coffield K; Hasan Rajab M; Jo C
    Asian J Androl; 2013 Mar; 15(2):246-8. PubMed ID: 23353723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and tolerance of PDE-5 in the treatment of erectile dysfunction in schizophrenic patients: A literature review].
    Bacconi L; Gressier F
    Encephale; 2017 Feb; 43(1):55-61. PubMed ID: 27658991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PDE-5i combined with RigiScan-based audiovisual sexual stimulation test versus nocturnal penile tumescence test in evaluation of erectile function].
    Sun XL; Ashok R; Gao QQ; Song T; Yu W; Xu ZP; Sun GH; Dai YT
    Zhonghua Nan Ke Xue; 2020 Jul; 26(7):601-604. PubMed ID: 33377714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis.
    Mykoniatis I; Pyrgidis N; Sokolakis I; Ouranidis A; Sountoulides P; Haidich AB; van Renterghem K; Hatzichristodoulou G; Hatzichristou D
    JAMA Netw Open; 2021 Feb; 4(2):e2036337. PubMed ID: 33599772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of statins on erectile dysfunction: a systematic review and meta-analysis.
    Cui Y; Zong H; Yan H; Zhang Y
    J Sex Med; 2014 Jun; 11(6):1367-75. PubMed ID: 24628781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212.
    Saito S; Fujita S; Mizusawa J; Kanemitsu Y; Saito N; Kinugasa Y; Akazai Y; Ota M; Ohue M; Komori K; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2016 Dec; 42(12):1851-1858. PubMed ID: 27519616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Cui Y; Liu X; Shi L; Gao Z
    Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of short- and long-term, regular and on-demand regimens of phosphodiesterase type 5 inhibitors in treating erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.
    Tian D; Wang XY; Zong HT; Zhang Y
    Clin Interv Aging; 2017; 12():405-412. PubMed ID: 28260869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.
    Fojecki GL; Tiessen S; Osther PJ
    World J Urol; 2017 Jan; 35(1):1-9. PubMed ID: 27108421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
    Yan H; Zong H; Cui Y; Li N; Zhang Y
    J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease.
    Lindsey I; George B; Kettlewell M; Mortensen N
    Dis Colon Rectum; 2002 Jun; 45(6):727-32. PubMed ID: 12072621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.